PANACEA LIFE SCIENCES HOLDINGS, INC. Annual Nonoperating Income (Expense) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
  • Panacea Life Sciences Holdings, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$389K, a 22.5% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$2.36M, a 17.5% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.47M, a 29.3% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.49M, a 402% decline from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $1.15M, a 4339% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.47M +$1.02M +29.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$3.49M -$4.65M -402% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.15M +$1.13M +4339% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $26K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.